Qube Research & Technologies Ltd - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 785 filers reported holding GLAXOSMITHKLINE PLC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q1 2022$16,258,000
+469.9%
373,241
+476.9%
0.14%
+527.3%
Q4 2021$2,853,000
-43.2%
64,698
-50.8%
0.02%
-65.1%
Q3 2021$5,020,000
+46.2%
131,369
+36.5%
0.06%
+16.7%
Q1 2021$3,434,000
+46.5%
96,215
+51.1%
0.05%
+63.6%
Q4 2020$2,344,000
-52.4%
63,691
-51.3%
0.03%
-52.9%
Q3 2020$4,927,000
+51.7%
130,901
+64.4%
0.07%
+45.8%
Q2 2020$3,247,000
+232.0%
79,600
+282.5%
0.05%
+54.8%
Q4 2019$978,000
-7.6%
20,813
-23.2%
0.03%
-92.4%
Q1 2018$1,058,00027,0980.41%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2018
NameSharesValueWeighting ↓
KAHN BROTHERS GROUP INC 1,282,289$46,483,4037.25%
Columbia Asset Management 9,960$3610.08%
PARK CIRCLE Co 800$29,0000.03%
PARADIGM ASSET MANAGEMENT CO LLC 1,800$65,2500.02%
Byrne Asset Management LLC 56$2,0000.00%
Retirement Group, LLC 40$1,4500.00%
Bartlett & Co. LLC 240$90.00%
HUNTINGTON NATIONAL BANK 1$400.00%
View complete list of GLAXOSMITHKLINE PLC shareholders